KLOW Blend Research Guide: KPV, GHK-Cu, BPC-157 & TB-500 Combined

KLOW is a proprietary research peptide blend supplied by RetaLABS as a lyophilised powder in an 80mg vial. Each vial contains four peptides with complementary and synergistic mechanisms:

• KPV (10mg) — Lys-Pro-Val, C-terminal fragment of α-MSH; NF-κB inhibitor with anti-inflammatory and gut epithelial barrier properties
• GHK-Cu (50mg) — Glycyl-L-histidyl-L-lysine copper complex; wound healing, collagen synthesis, and antioxidant signalling
• BPC-157 (10mg) — Body Protection Compound-157; angiogenesis via VEGF, tendon/gut repair, FAK/paxillin pathway activation
• TB-500 (10mg) — Thymosin Beta-4 synthetic analogue; actin polymerisation regulation, cell migration, and inflammatory modulation

The blend is formulated for researchers who wish to investigate synergistic tissue repair and anti-inflammatory mechanisms without requiring separate reconstitution, storage, and administration of four individual compounds.

KPV is the C-terminal tripeptide of α-melanocyte-stimulating hormone (α-MSH). Its primary mechanism is inhibition of NF-κB nuclear translocation, reducing pro-inflammatory cytokine production (IL-1β, IL-6, TNF-α). KPV also acts directly on intestinal epithelial cells to reduce inflammatory signalling and has shown protective effects in colitis models. See the KPV Research Guide for full detail.

GHK-Cu (copper peptide GHK) is a naturally occurring plasma tripeptide that declines with age. It activates over 30 genes associated with wound healing and tissue remodelling, promotes collagen and glycosaminoglycan synthesis, and acts as an antioxidant through copper-mediated superoxide dismutase-like activity. It also upregulates VEGF and fibroblast growth factors relevant to angiogenesis.

BPC-157 contributes angiogenic activity via VEGF upregulation, fibroblast stimulation, and FAK/paxillin pathway activation — mechanisms that complement GHK-Cu's pro-healing effects at the extracellular matrix level. See the BPC-157 Research Guide for mechanistic detail.

TB-500 is a synthetic fragment corresponding to the active region of Thymosin Beta-4 (Tβ4), a ubiquitous 43-amino acid actin-sequestering peptide. TB-500 regulates actin polymerisation critical to cell migration and promotes anti-inflammatory signalling. Its role in cardiac and skeletal muscle repair models has generated significant research interest.

Each component of KLOW targets distinct but overlapping repair pathways, providing a rational basis for combination research:

• Anti-inflammatory convergence — KPV (NF-κB inhibition) and TB-500 (inflammatory modulation) act on inflammation through different upstream mechanisms, potentially producing additive suppression of pro-inflammatory cascades
• Angiogenic complementarity — BPC-157 (VEGF-driven) and GHK-Cu (VEGF + FGF-driven) both promote vascularisation of healing tissue through partially distinct receptor-mediated pathways
• Matrix remodelling — GHK-Cu drives collagen and GAG synthesis while BPC-157 promotes fibroblast migration via FAK/paxillin signalling — sequential processes in tissue repair
• Cell migration — TB-500's actin regulatory function and BPC-157's fibroblast proliferation effects combine to accelerate cellular infiltration of wound beds

Researchers investigating complex wound healing models, inflammatory tissue injury, or post-surgical recovery mechanisms may find the multi-pathway coverage of KLOW useful for establishing baseline combination effects prior to dose-ranging studies with individual components.

RetaLABS KLOW 80mg is in stock and ships Express Post Australia-wide within 1–2 business days of confirmed payment. Supplied with a manufacturer COA covering identity and purity of each component.

Reconstitution: add 2–4mL bacteriostatic water depending on desired working concentration, injecting slowly along the vial wall. Gently swirl until fully dissolved. Store lyophilised at −20°C protected from light; reconstituted solution at 2–8°C for up to 4 weeks. Note that GHK-Cu is a copper-chelated peptide — use standard laboratory plasticware rather than metal-contaminated glassware or syringes. See the Peptide Reconstitution Guide for full protocol. For laboratory research use only.